Skip to main content
Clinical Trials/CTRI/2021/01/030762
CTRI/2021/01/030762
Completed
N/A

A single centre, prospective, observational study to evaluate the efficacy and safety of Colistin with double carbapenem regimen versus other antimicrobial combinations with colistin for treatment of carbapenem resistant enterobacteriaceae infections.

Roopali Somani0 sites46 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Roopali Somani
Enrollment
46
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 10, 2022
Last Updated
last year
Study Type
Observational

Investigators

Sponsor
Roopali Somani

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years and above of any gender
  • 2\. Inpatients with positive culture for Carbapenem Resistant Enterobactericeae
  • 3\. Subjects willing to comply with study related procedures

Exclusion Criteria

  • 1\. Patients with history of Epilepsy
  • 2\. Patients with Creatinine Clearance \<30 ml/min
  • 3\. Patients with any comorbidities that is known to affect the study outcome
  • 4\. Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials